Medtronic (NYSE: MDT) + today announced that it filed a complaint to the U.S. International Trade Commission (ITC) to block the sales of certain Axonics (Nasdaq:AXNX) devices.
The complaint to the ITC runs parallel to action in the U.S. District Court for the District of Delaware. Medtronic wants to block Axonics from “improperly importing and selling products that infringe two of its patents related to the MRI compatibility of implantable medical devices.”
Medtronic wants the ITC to investigate and exclude the importation of Axonics products believed by the company to infringe its patents. The company has a separate infringement suit pending in the U.S. District Court for the Central District of California as well. That suit asserts that Axonics infringed additional technologies developed by and belonging to Medtronic.
“Medtronic is continuing our efforts to stop Axonics from profiting off of …